Beike and Peking University International Hospital join forces to advance stem cell therapy
Two of Asia’s most prominent names in regenerative medicine and clinical research are joining forces with a shared mission to bring advanced stem cell treatments to patients with autoimmune disease, type 2 diabetes, and other intractable conditions. On May 11, 2026, Dr. Hu Junyuan, founder and chairman of Shenzhen Beike Biotechnology, and Academician Wei Yuquan of … Read more